Followers | 230 |
Posts | 15196 |
Boards Moderated | 0 |
Alias Born | 03/30/2005 |
Tuesday, September 29, 2020 11:51:35 AM
We have the June 5th breadcrumb (been posted numerous times over the last few months by many)
Then why are these other companies able to clearly name GMU
https://science.gmu.edu/news/chimeron-bio-and-george-mason-university-ncbid-partner-covid-19-vaccine-using-chaesartm
https://emergexvaccines.com/emergex-signs-agreement-with-george-mason-university-for-highly-pathogenic-rna-virus-studies/
What was so special about Brilacidin in the beginning, or IPIX, that we are constantly covered in a shroud of secrecy. Maybe Leo likes cloak and dagger approach, but wall street does not. He and another board member are literally next door neighbors. Is that a coincidence or just looking out for good friends? Wish he treated investors with courtesy.
I tried calling the company - no answer. no call back. emails go unanswered.
I try 1x per month to email gmu. nothing. i don't blame them cause ipix should be updating investors and not some reasearcher.... but i iwll keep sending her ipix pr's and eventually the head of gmu to see what's going on in ipix land. hate me. like me. it doesn't matter. for the peeps that got upset by my sec comment, it should not bother you if you believe in ipix unless you too have your doubts. tread lightly
the above is all IMHO (consider this my safe harbor statement)
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM